» Articles » PMID: 34376770

Association of Rs3750920 Polymorphism in TOLLIP with Clinical Characteristics of Fibrosing Interstitial Lung Diseases in Japanese

Overview
Journal Sci Rep
Specialty Science
Date 2021 Aug 11
PMID 34376770
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

TOLLIP polymorphism has been implicated in the development and prognosis of idiopathic pulmonary fibrosis (IPF), mainly in whites. However, ethnic differences in the characteristics of other interstitial pneumonia (non-IPF) subtypes are unclear. We evaluated the association between the rs3750920 genotype and the clinical characteristics of Japanese patients with fibrosing interstitial lung diseases (ILD). We genotyped 102 patients with fibrosing ILD (75 IPF and 27 non-IPF patients) and analyzed the interaction between the rs3750920 genotype distribution and their clinical characteristics. The overall frequencies of the C/C, C/T, and T/T genotypes were 69%, 25%, and 6%, respectively. The proportion of minor T allele carriers was larger in IPF patients than in non-IPF patients (37% vs. 15%, P = 0.031). In addition, survival at 3 years was significantly better for carriers than for non-carriers of the T allele. There was no significant association between genotype distribution and change in pulmonary function after introduction of antifibrotic agents. The frequency of the minor T allele of rs3750920 was low in Japanese patients with fibrosing ILD, particularly in non-IPF patients. Carriers of the minor T allele had better survival than non-carriers. Presence of the T allele might thus be an indicator of better outcomes for fibrosing ILD.

Citing Articles

Navigating interstitial lung disease associated with rheumatoid arthritis (RA-ILD): from genetics to clinical landscape.

Bernardinello N, Zen M, Castelli G, Cocconcelli E, Balestro E, Borie R Front Med (Lausanne). 2025; 12:1542400.

PMID: 40066169 PMC: 11891064. DOI: 10.3389/fmed.2025.1542400.


Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences.

Cerri S, Manzini E, Nori O, Pacchetti L, Rossi L, Turchiano M Medicina (Kaunas). 2025; 60(12.

PMID: 39768847 PMC: 11677115. DOI: 10.3390/medicina60121967.


Associations between genetic variants of Toll-interacting proteins and interstitial lung diseases: a systematic review and meta-analysis.

Li X, Cui B, Jiang L Orphanet J Rare Dis. 2024; 19(1):432.

PMID: 39578840 PMC: 11583435. DOI: 10.1186/s13023-024-03410-8.


Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations.

Sampsonas F, Bosgana P, Bravou V, Tzouvelekis A, Dimitrakopoulos F, Kokkotou E Genes (Basel). 2024; 15(7).

PMID: 39062713 PMC: 11276289. DOI: 10.3390/genes15070934.


Immune mechanisms in fibrotic interstitial lung disease.

Kamiya M, Carter H, Espindola M, Doyle T, Lee J, Merriam L Cell. 2024; 187(14):3506-3530.

PMID: 38996486 PMC: 11246539. DOI: 10.1016/j.cell.2024.05.015.


References
1.
Homma S, Azuma A, Taniguchi H, Ogura T, Mochiduki Y, Sugiyama Y . Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis. Respirology. 2012; 17(3):467-77. DOI: 10.1111/j.1440-1843.2012.02132.x. View

2.
Bhattacharyya S, Kelley K, Melichian D, Tamaki Z, Fang F, Su Y . Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol. 2012; 182(1):192-205. PMC: 3538029. DOI: 10.1016/j.ajpath.2012.09.007. View

3.
Go H, Koh J, Kim H, Jeon Y, Chung D . Expression of toll-like receptor 2 and 4 is increased in the respiratory epithelial cells of chronic idiopathic interstitial pneumonia patients. Respir Med. 2014; 108(5):783-92. DOI: 10.1016/j.rmed.2013.12.007. View

4.
Sakamoto S, Kataoka K, Kondoh Y, Kato M, Okamoto M, Mukae H . Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial. Eur Respir J. 2020; 57(1). DOI: 10.1183/13993003.00348-2020. View

5.
Stuart B, Lee J, Kozlitina J, Noth I, Devine M, Glazer C . Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir Med. 2014; 2(7):557-65. PMC: 4136521. DOI: 10.1016/S2213-2600(14)70124-9. View